Scarica l'app Stockscreener
0.334
3.77%
-0.0131
Dopo l'orario di chiusura:
.33
-0.004
-1.20%
Precedente Chiudi:
$0.3471
Aprire:
$0.356
Volume 24 ore:
612.27K
Relative Volume:
0.09
Capitalizzazione di mercato:
$9.51M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-0.4123
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
-6.55%
1M Prestazione:
+36.33%
6M Prestazione:
-52.96%
1 anno Prestazione:
-87.54%
Intervallo 1D:
$0.33
$0.3627
Intervallo di 1 settimana:
$0.33
$0.375
Portata 52W:
$0.1639
$2.81
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.334 | 9.88M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
What analysts say about bioAffinity Technologies Inc. stockExtraordinary profit generation - PrintWeekIndia
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockSuperior profit margins - PrintWeekIndia
bioAffinity Technologies Approves Key Proposals at Annual Meeting - TipRanks
Is bioAffinity Technologies Inc. Equity Warrant stock a good hedge against inflationHigh-velocity capital appreciation - jammulinksnews.com
When is the best time to buy bioAffinity Technologies Inc. Equity Warrant stockMarket-beating returns - jammulinksnews.com
Will bioAffinity Technologies Inc. stock benefit from interest rate changesSkyrocketing investment returns - jammulinksnews.com
What institutions are buying bioAffinity Technologies Inc. stock nowConsistent triple returns - jammulinksnews.com
What drives bioAffinity Technologies Inc. stock priceDynamic growth stocks - Autocar Professional
bioAffinity’s CyPath® Lung Test Identifies Missed Tumor - TipRanks
Breakthrough: New Lung Cancer Test Catches Hidden Stage 1A Tumor Other Diagnostics Missed - Stock Titan
The BIAF Stock Puzzle: Unraveling BioAffinity Technologies Inc’s Fluctuating Performance - investchronicle.com
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentHigh-yield investments - jammulinksnews.com
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
bioAffinity Technologies obtains Canadian patent for lung cancer spit test - Mugglehead Magazine
bioAffinity Technologies Inc. Stock Analysis and ForecastOver 200% growth - jammulinksnews.com
Is bioAffinity Technologies Inc. a good long term investmentLightning-fast capital gains - jammulinksnews.com
What drives bioAffinity Technologies Inc. Equity Warrant stock priceExceptional risk-adjusted gains - jammulinksnews.com
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection - TipRanks
Published on: 2025-07-22 10:16:37 - Newser
bioAffinity Technologies secures Canadian patent for lung cancer test By Investing.com - Investing.com India
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastBreakout profit opportunities - jammulinksnews.com
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.50%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):